Joanna Holder
Medical · Gainesville, GANPI 1487164596
Payments from drug & device makers
Across 82 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$226
- Dexcom, Inc.$179
- Novo Nordisk$165
- AbbVie$131
- Lilly USA, LLC$110
- Boehringer Ingelheim$107
- plus $701 from 13 others
What the payments were for
- Food & beverage$1,618100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $226 |
| Dexcom, Inc. | 4 | $179 |
| Novo Nordisk | 8 | $165 |
| AbbVie | 7 | $131 |
| Lilly USA, LLC | 6 | $110 |
| Boehringer Ingelheim | 6 | $107 |
| Vifor Pharma, Inc. | 6 | $106 |
| AstraZeneca(2 entities) | 5 | $94 |
| Amgen(2 entities) | 6 | $81 |
| Bayer | 4 | $77 |
| Pfizer | 3 | $59 |
| Exact Sciences | 3 | $56 |
| Akebia Therapeutics Inc | 3 | $54 |
| Astellas Pharma US Inc | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Inogen, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,618 in reported general payments places this provider in the 60th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $27,923 |
| OzempicSemaglutide | 17 | $24,175 |
| RybelsusSemaglutide | 15 | $14,940 |
| EliquisApixaban | 13 | $11,113 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 11 | $7,641 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,863 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,847 |
| SynthroidLevothyroxine Sodium | 21 | $1,881 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 14 | $1,014 |
| Valsartan | 20 | $880 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $811 |
| Amlodipine Besylate | 132 | $715 |
| Atorvastatin Calcium | 85 | $639 |
| Diclofenac Sodium | 12 | $367 |
| Simvastatin | 26 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $165 | $39,11432 claims |
| Lilly USA, LLCMounjaro | $110 | $27,92325 claims |
| PfizerEliquis | $59 | $11,11313 claims |
| Boehringer IngelheimTrijardy Xr | $107 | $7,64111 claims |
| AbbVieSynthroid | $131 | $1,88121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 950 medical providers in Georgia.
Other medical in Gainesville
- Audrey GibsonGainesville$302K
- Justin SmithGainesville$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.